In observation of National PA Week, Moffitt PA Mark Honor details top-of-license nursing collaboration and outpatient ...

NP Theresa Stukus and NP Nelli Zafman discuss practical strategies for preventing, monitoring, and managing oral and ocular toxicities in patients with metastatic triple-negative breast cancer (mTNBC) ...

The University of Kansas Cancer Center The University of South Alabama, Mitchell Cancer Institute The University of Texas MD Anderson Cancer Center The Winthrop P. Rockefeller Cancer Institute at the ...

NP Theresa Stukus and NP Nelli Zafman discuss the practical challenges patients with metastatic triple-negative breast cancer ...

OncologyLive: Caregiver Connection | Publications | Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.

Rev. Diane Baldwin is manager of Oncology Navigation Programs at the University of South Alabama Mitchell Cancer Institute (MCI) where she is also appointed as Chaplain. She is a member of the Academy ...

Adding atezolizumab to adjuvant FOLFOX halved the risk of recurrence or death in ATOMIC, with more grade 3 to 4 adverse events. The FDA has approved atezolizumab (Tecentriq) in combination with a ...

In this podcast, experts Emely Alfaro, DNP, RN, CNS, OCN, Marianne Davies, NP, DNP, MSN, APRN, BSN, and Stephanie McDonald, MSN, FNP-BC, AOCNP, discuss how to ...

Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission. At the 23rd Annual Meeting & Exposition of the International ...

The U.S. Food and Drug Administration (FDA) approved tucatinib (Tukysa, Seagen Inc., a subsidiary of Pfizer) on October 7, ...